Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin for Cerebral Venous Thrombosis: An Updated Systematic Review and Meta-analysis (P3-5.010) | Synapse
June 13, 2026
Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin for Cerebral Venous Thrombosis: An Updated Systematic Review and Meta-analysis (P3-5.010)
Key Points
This research aims to assess the safety and efficacy of direct oral anticoagulants compared to warfarin for cerebral venous thrombosis.
Conducted a systematic review and meta-analysis of existing studies comparing DOACs and warfarin.
Included various studies evaluating treatment outcomes for CVT using DOACs or warfarin.
DOACs demonstrated comparable efficacy to warfarin for treating CVT with a lower incidence of major bleeding events.
Findings suggest that DOACs are potentially safer, making them a viable alternative to warfarin for CVT treatment.
Abstract
To compare the safety and efficacy of direct oral anticoagulants (DOACs) versus warfarin for the treatment of Cerebral Venous Thrombosis (CVT).